BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 11175345)

  • 1. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination.
    Benvenuto G; Li S; Brown SJ; Braverman R; Vass WC; Cheadle JP; Halley DJ; Sampson JR; Wienecke R; DeClue JE
    Oncogene; 2000 Dec; 19(54):6306-16. PubMed ID: 11175345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
    Plank TL; Logginidou H; Klein-Szanto A; Henske EP
    Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles.
    Plank TL; Yeung RS; Henske EP
    Cancer Res; 1998 Nov; 58(21):4766-70. PubMed ID: 9809973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration.
    Astrinidis A; Cash TP; Hunter DS; Walker CL; Chernoff J; Henske EP
    Oncogene; 2002 Dec; 21(55):8470-6. PubMed ID: 12466966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense suppression of TSC1 gene product, hamartin, enhances neurite outgrowth in NGF-treated PC12h cells.
    Floricel F; Higaki K; Maki H; Nanba E; Ninomiya H; Ohno K
    Brain Dev; 2007 Sep; 29(8):502-9. PubMed ID: 17376623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of TSC2 stop codon variants found in tuberous sclerosis patients.
    Goedbloed MA; Nellist M; Verhaaf B; Reuser AJ; Lindhout D; Sunde L; Verhoef S; Halley DJ; van den Ouweland AM
    Eur J Hum Genet; 2001 Nov; 9(11):823-8. PubMed ID: 11781698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin.
    Wei J; Li P; Chiriboga L; Mizuguchi M; Yee H; Miller DC; Greco MA
    Pediatr Dev Pathol; 2002; 5(5):448-64. PubMed ID: 12202993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin.
    Hodges AK; Li S; Maynard J; Parry L; Braverman R; Cheadle JP; DeClue JE; Sampson JR
    Hum Mol Genet; 2001 Dec; 10(25):2899-905. PubMed ID: 11741833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberous sclerosis genes regulate cellular 14-3-3 protein levels.
    Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
    Biochem Biophys Res Commun; 2003 Dec; 312(3):676-83. PubMed ID: 14680818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct effects of single amino-acid changes to tuberin on the function of the tuberin-hamartin complex.
    Nellist M; Sancak O; Goedbloed MA; Rohe C; van Netten D; Mayer K; Tucker-Williams A; van den Ouweland AM; Halley DJ
    Eur J Hum Genet; 2005 Jan; 13(1):59-68. PubMed ID: 15483652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cell morphology and adhesion by the tuberous sclerosis complex (TSC1/2) gene products in human kidney epithelial cells through increased E-cadherin/beta-catenin activity.
    Li S; Braverman R; Li H; Vass WC; Lowy DR; DeClue JE
    Mol Carcinog; 2003 Jun; 37(2):98-109. PubMed ID: 12766909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.
    Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH
    Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hamartin and tuberin expression in human tissues.
    Johnson MW; Kerfoot C; Bushnell T; Li M; Vinters HV
    Mod Pathol; 2001 Mar; 14(3):202-10. PubMed ID: 11266527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis.
    Aicher LD; Campbell JS; Yeung RS
    J Biol Chem; 2001 Jun; 276(24):21017-21. PubMed ID: 11290735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberous sclerosis causing mutants of the TSC2 gene product affect proliferation and p27 expression.
    Soucek T; Rosner M; Miloloza A; Kubista M; Cheadle JP; Sampson JR; Hengstschläger M
    Oncogene; 2001 Aug; 20(35):4904-9. PubMed ID: 11521203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex.
    Nellist M; Verhaaf B; Goedbloed MA; Reuser AJ; van den Ouweland AM; Halley DJ
    Hum Mol Genet; 2001 Dec; 10(25):2889-98. PubMed ID: 11741832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner.
    Astrinidis A; Senapedis W; Henske EP
    Hum Mol Genet; 2006 Jan; 15(2):287-97. PubMed ID: 16339216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular response to ectopic overexpression of the tuberous sclerosis genes, TSC1 and TSC2: a proteomic approach.
    Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
    Int J Oncol; 2005 Sep; 27(3):831-8. PubMed ID: 16077935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteins interacting with the tuberous sclerosis gene products.
    Rosner M; Freilinger A; Hengstschläger M
    Amino Acids; 2004 Oct; 27(2):119-28. PubMed ID: 15351877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners.
    Rosner M; Hanneder M; Siegel N; Valli A; Hengstschläger M
    Mutat Res; 2008; 658(3):234-46. PubMed ID: 18291711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.